« Forschungslandschaft: Projekte
Pharmakodynamik von Tyrosinkinaseinhibitoren
Finanzierung:
Stiftungen - Sonstige;
This analysis will give a deeper insight into the molecular events required for biological activity of TKIs and will directly translate into clinical application:
(1) In development of appropriate therapeutic TKI dosing schedules,
(2) development of novel chemical compounds that lead to cytoplasmatic retention or accumulation and
(3) a change in the perception of specific biochemical markers to monitor patients for drug response.
(1) In development of appropriate therapeutic TKI dosing schedules,
(2) development of novel chemical compounds that lead to cytoplasmatic retention or accumulation and
(3) a change in the perception of specific biochemical markers to monitor patients for drug response.
Anmerkungen
Schlagworte:
Myeloproliferative Neoplasien, Pharmakodynamik, TKI, TYrosine kinase
Myeloproliferative Neoplasien, Pharmakodynamik, TKI, TYrosine kinase